HIV Prevention

/HIV Prevention
HIV Prevention 2013-11-18T07:53:26+00:00

[av_layerslider id=’5′]

[av_textblock ]

HIV Prevention

HIV prevention is an integral part of all CIDRZ programme and research activities. In addition, CIDRZ supports the Ministry of Health in its scale up of voluntary medical male adult circumcision – and the faster and safer early infant circumcision for newborn boys – both important public health HIV prevention methods.

HIV Prevention Services

Individual, provider initiated, and couples HIV counselling and testing factor into all CIDRZ programmes. Those found with HIV are linked to care and are provided with the information, counselling and support necessary to live positively, while those found to be negative are provided with the information and encouragement necessary to maintain that status.

Several of CIDRZ programmes engage the community by spearheading support groups to give people living with HIV and AIDS a platform to meet in a safe space, share experiences and receive information on adherence and healthy living. These programmes also train local peer educators on adherence counseling, community mobilisation, communication skills, conflict management and HIV/AIDS basics while Neighbourhood Health Committees promote community involvement in health issues and address individual communities’ needs.

CIDRZ also supports the Zambian government’s Voluntary Medical Male Circumcision strategy by expanding coverage of both adult male and early infant male circumcision. Learn more —>

Research on HIV Prevention

CIDRZ researchers engage in and support research activities on HIV prevention in Zambia. Since 2002, CIDRZ has actively participated in the quest to test new tools that women could use to prevent themselves from acquiring HIV. Initially participating in the HIV Prevention Trials Network (HPTN) 035 Standard of Care Assessment and the HPTN 055 Prevention Preparatory Study, the CIDRZ Microbicide Trials Network team at the Kamwala Clinical Research Site completed the HPTN 035 Phase II/IIb trial comparing the non-specific topical microbicides BufferGel and 0.5% concentration of PRO 2000 against placebo gel, receiving an award for data quality.

In 2010 CIDRZ collaborated with the University of Zambia to conduct an acceptability and feasibility study of Neonatal Male Circumcision. Following that study’s recommendations, CIDRZ has supported the government by providing medical circumcision to over 8000 infant boys.

Presently, CIDRZ is partnering with the University of North Carolina at Chapel Hill to implement and evaluate a pilot programme to increase demand for voluntary adult male circumcision in Zambia’s Southern Province. Additionally, we are also supporting The Population Effects of Immediate ART to reduce HIV Transmission (PopART) study which will examine the impact of a combination prevention strategy, including early antiretroviral therapy on population level HIV incidence in Zambia and South Africa. The PopART study is run and managed by the HIV Prevention Trials Network.